These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30312468)

  • 1. The Debate About Nicotine Regulation: Commentary on Zeller.
    Myers ML
    Nicotine Tob Res; 2019 Feb; 21(3):335. PubMed ID: 30312468
    [No Abstract]   [Full Text] [Related]  

  • 2. The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller.
    Hatsukami DK; Donny EC
    Nicotine Tob Res; 2019 Feb; 21(3):338-339. PubMed ID: 30312443
    [No Abstract]   [Full Text] [Related]  

  • 3. The Nicotine Continuum and Regulation: Additional Challenges to Converting an Important Concept into Policy: Commentary on Zeller.
    Warner KE
    Nicotine Tob Res; 2019 Feb; 21(3):333-334. PubMed ID: 30312444
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on the nicotine is/is not addictive debate.
    Jaffe JH
    Psychopharmacology (Berl); 1995 Jan; 117(1):21-2. PubMed ID: 7724698
    [No Abstract]   [Full Text] [Related]  

  • 5. The United States is not the World: Response to Zeller et al's Call for Discussion on Nicotine Regulation.
    West R
    Nicotine Tob Res; 2019 Feb; 21(3):344. PubMed ID: 30312456
    [No Abstract]   [Full Text] [Related]  

  • 6. Winners and Losers: Communicating the Potential Impacts of Policies: Commentary on Zeller.
    Brick C; Spiegelhalter DJ
    Nicotine Tob Res; 2019 Feb; 21(3):336-337. PubMed ID: 30312453
    [No Abstract]   [Full Text] [Related]  

  • 7. Acting Now Is Urgent: Commentary on Zeller.
    Nicotine Tob Res; 2019 Sep; 21(10):1448. PubMed ID: 30590816
    [No Abstract]   [Full Text] [Related]  

  • 8. Acting Now Is Urgent: Commentary on Zeller.
    Proctor RN
    Nicotine Tob Res; 2019 Feb; 21(3):340-341. PubMed ID: 30312452
    [No Abstract]   [Full Text] [Related]  

  • 9. The neurobiology of tobacco dependence: a commentary.
    Balfour DJ
    Respiration; 2002; 69(1):7-11. PubMed ID: 11844955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on Hatsukami et al. (2010): building the science base for tobacco product regulation-nicotine reduction.
    Zeller M; Shiffman S
    Addiction; 2010 Feb; 105(2):356-7. PubMed ID: 20078492
    [No Abstract]   [Full Text] [Related]  

  • 11. A revision of the Elachista dispilella complex (Lepidoptera: Gelechioidea: Elachistidae).
    Kaila L; Baran T; Mutanen M
    Zootaxa; 2015 May; 3963(4):517-60. PubMed ID: 26249413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on Nardone et al. (2016): Satisfaction, dissatisfaction and complicating the nicotine-reduction strategy with more nicotine.
    Kozlowski LT
    Addiction; 2016 Dec; 111(12):2217-2218. PubMed ID: 28075539
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13.
    Wolters A; de Wert G; van Schayck OC; Horstman K
    Addiction; 2014 Aug; 109(8):1268-73. PubMed ID: 24889653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial Commentary: Nicotine in electronic cigarettes: Cardiovascular harm reduction, not elimination.
    Tindle HA; Freiberg MS
    Trends Cardiovasc Med; 2016 Aug; 26(6):524-5. PubMed ID: 27155811
    [No Abstract]   [Full Text] [Related]  

  • 15. Rethinking therapeutic and recreational nicotine products: a commentary on Hatsukami et al.
    Borland R; Gartner C
    Tob Control; 2016 May; 25(3):245. PubMed ID: 27103635
    [No Abstract]   [Full Text] [Related]  

  • 16. The place for harm reduction and product regulation in UK tobacco control policy.
    Gilmore AB; Britton J; Arnott D; Ashcroft R; Jarvis MJ
    J Public Health (Oxf); 2009 Mar; 31(1):3-10. PubMed ID: 19109341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A licence to vape: Is it time to trial of a nicotine licensing scheme to allow Australian adults controlled access to electronic cigarettes devices and refill solutions containing nicotine?
    Gartner C; Hall W
    Int J Drug Policy; 2015 Jun; 26(6):548-53. PubMed ID: 25817484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on Goniewicz et al. (2014): if wisely regulated, electronic cigarettes can make cigarettes obsolete.
    Etter JF
    Addiction; 2014 Mar; 109(3):508-9. PubMed ID: 24524322
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on: "Effects of scopolamine and nicotine on human rapid information processing performance." Psychopharmacology (1984) 82:147-150. Nicotine improves information processing: saying the unthinkable.
    Warburton DM
    Psychopharmacology (Berl); 2002 Aug; 162(4):345-8. PubMed ID: 12172687
    [No Abstract]   [Full Text] [Related]  

  • 20. Petasites--Zeller: ZE 339.
    Drugs R D; 2003; 4(6):378-9. PubMed ID: 14584971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.